Kopetz, S , Boni, V, Kato, K, Raghav, KS, Vieito, M, Pallis, A, Habermehl, C, Siddiqui, A, Courlet, P, Sloot, W, Raab-Westphal, S, Hart, F, Rodriguez-Rivera, I
(ii) As a delayed regimen, the therapy (BPC 157 or saline (5 mL/kg)) was given as an intragastric administration at 4.30 h of ligation time for assessment at 5 h of ligation time, or BPC 157 as an oral administration, given continuously in drinking water from 5 h of ligation time until the sacrifice at 24 h of ligation time (0.16 g/mL/rat, 0.16 ng/mL/rat) while controls received drinking water only (12 mL/day/rat)
The theoretical concern remains unconfirmed in humans but is biologically plausible given the peptide's pro-vascular activity
Want to Learn More About Olympia Vita-Complex?